CF vs IMRX · P/E 12, rev $5.94B vs $124.2M cap
CF Industries Holdings Inc (CF) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
CF currently screens at market cap $14.98B and trailing P/E 12.2. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the CF and IMRX stock pages for the full models.
Not investment advice.